CAR-NK Cell Therapy: A Transformative Approach to Overcoming Oncological Challenges
The use of chimeric antigen receptor (CAR) in natural navy blue maang tikka killer (NK) cells for cancer therapy is gaining momentum, marking a significant shift in cancer treatment.This review aims to explore the potential of CAR-NK cell therapy in cancer immunotherapy, providing a fresh perspective.It discusses the innovative approaches in CAR-NK